Avicenna Biosciences has received its first patent covering new ROCK inhibitor compounds that may be used to treat amyotrophic…
Articles by Esteban Dominguez Cerezo, MS
Measuring the levels of a novel protein biomarker called C-X-C motif chemokine ligand 12 — CXCL12 for short —…
S-oxprenolol, an investigational therapy being developed by Actimed Therapeutics to treat muscle wasting in amyotrophic lateral sclerosis (ALS), has…
EverythingALS has launched a new version of its mobile app that now includes community support, artificial intelligence-powered chat assistance,…
Two U.S. representatives have introduced legislation that would establish a federally funded research program to study the link between environmental…
Dewpoint Therapeutics has won a second grant from Target ALS Foundation to advance preclinical studies of its experimental…
A consortium of amyotrophic lateral sclerosis (ALS) nonprofits and industry stakeholders has launched Project Mosaic, an initiative that…
A researcher at Penn State University has received a $250,000 grant for an innovative project that seeks to identify and…
Estimates from the World Health Organization suggest 1 in 4 people are likely to be diagnosed with a neurodegenerative condition.
Diamir Biosciences has received a patent in the European Union that covers the use of microRNAs (miRNAs), that is,…